The data do not support statin use in primary prevention of cardiovascular events for women, and any advertising claims made by drugmakers are vulnerable to legal action, according to one legal expert. Cardiologists, however, argue that the absence of information doesn’t mean the drugs don’t work in women, and they continue to prescribe them.
Heartwire
Doctors and Lawyers Butt Heads Over Statins for Primary Prevention in Women
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Avigen Announces Restructuring and Strategic Direction
Published in November 3rd, 2008
Comments Off
ALAMEDA, Calif., November 3, 2008 — Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced a significant restructuring of the company aimed at preserving cash and reassessing its…
What Experience Shaped You?
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Every pharmacist can remember an experience that influenced his or her professional and personal development. Now you have a chance to share your story with others.
Medscape Pharmacists
Coordinated Headache Management Improves Outcomes
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
A practical headache management program aimed at filling the gaps in traditional care leads to a marked improvement in patients’ quality of life and satisfaction with treatment, according to findings published in the October issue of Headache.
Reuters Health Information
Coordinated Headache Management Improves Outcomes
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
A practical headache management program aimed at filling the gaps in traditional care leads to a marked improvement in patients’ quality of life and satisfaction with treatment, according to findings published in the October issue of Headache.
Reuters Health Information
Balance of Risks May Favor Warfarin Resumption After Stopping Because of an ICH
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
After an intracerebral hemorrhage (ICH) necessitates warfarin discontinuation, the risk of recurrent hemorrhage when warfarin is restarted may be lower than the risk of thromboembolic events if warfarin therapy is not reinitiated, investigators report.
Reuters Health Information
Medicare Part D Spending Down By $6B As Generic Drug Use Grows
Published in November 3rd, 2008
Posted by Pharma Industry / Biotech Industry News From Medical News Today in Pharmaceutical Industry News
Comments Off
Medicare prescription drug benefit spending in fiscal year 2008 totaled $44 billion — $6 billion lower than estimated — as the program experienced lower-than-expected enrollment, more use of low-cost generic drugs and beneficiaries reducing drug spending to avoid the program’s “doughnut hole,” USA Today reports.
General Mills Issues Voluntary Class One Recall Involving One Day’s Production of Progresso Hearty Tomato Soup (October 31)
Published in November 3rd, 2008
Posted by Food and Drug Administration--Recalls in Food and Nutrition Information, Safety Information
Comments Off
General Mills is voluntarily recalling a single day’s production of Progresso Hearty Tomato soup because of a product labeling issue. Product produced on this date may have been mislabeled, and may contain allergens not listed on the ingredient label, specifically egg, milk, and soy.
Tyrosine Kinase Inhibition May Be Beneficial Before Debulking Nephrectomy
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Tyrosine kinase inhibition (TKI) provides significant cytoreduction of renal cell carcinoma (RCC) prior to debulking nephrectomy, according to a report in the October issue of Urology.
Reuters Health Information
Appropriate Use of Aromatase Inhibitors in Early-Stage Breast Cancer
Published in November 3rd, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
This challenging series of patient simulations focuses on when — and when not — to prescribe aromatase inhibitor therapy in patients with early-stage breast cancer.
Medscape Hematology-Oncology